Home>Topics>Companies>Bayer AG

Bayer AG

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
  1. Bayer (BAYRY.PK) and Onyx Pharmaceuticals (ONXX) announce a Phase 3 trial of Nexavar tablets in patients with certain lung cancers did not meet its primary endpoint of improving overall survival.

    Headlines

    Tue, 22 May 2012

    Bayer ( BAYRY.PK ) and Onyx Pharmaceuticals ( ONXX ) announce a Phase 3 trial of Nexavar tablets in patients with certain lung cancers did not meet its primary endpoint of improving overall survival. Post your comment!

  2. China Biotech In Review: Surgical Instrument Acquisition Takes Mindray Into New Territory

    Headlines

    Mon, 14 May 2012

    the conference, including Aosaikang, AstraZeneca, Bayer HealthCare , BeiGene, Boehringer Ingelheim, Eli Lilly, Fosun Pharma, Furen Pharma, Hanmi Pharmaceutical, Hengrui Pharmaceuticals , Hua Medicine, Janssen/J&J, Life Technologies

  3. EWG iShares MSCI Germany Index ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Tue, 8 May 2012

    established global brands such as Siemens, Bayer , Daimler, and SAP. Given the export ..... such as Siemens, BASF, Daimler, and Bayer . That said, this fund has a cyclical ..... industries such as financial services, pharmaceuticals , and automobile manufacturing. EWG

  4. Stock Intersection bug re Bayer AG

    Commentary

    Fri, 4 May 2012

    Just looked at the intersection for two portfolios that have American Funds and others with holdings in Bayer AG . In both cases, each portfolio repeated the entry line 7 times with all having the same funds and values. Not a problem, just wanted to report this bug. John

  5. Onyx Reports In-Line 1Q as It Approaches Key Regulatory Decisions for Pipeline

    Commentary

    Thu, 3 May 2012

    Onyx Pharmaceuticals ' ONXX first-quarter results came in generally in line with our expectations ..... In first quarter, revenue from Onyx's collaboration agreement with Bayer BAYRY on Nexavar sales was $72.0 million, representing a 7% increase

  6. Maxygen: Bayer $30 Million Payment Likely In 2012

    Headlines

    Wed, 2 May 2012

    not yet become reflected in Maxygen's stock price. Bayer Healthcare ( BAYZF.PK ) recently disclosed in a recent investor ..... trading only modestly above cash, the realization of the Bayer payment will likely serve as a key catalyst that will

  7. New Morningstar Analyst Report - Bayer AG ADR

    Stock Reports

    Mon, 30 Apr 2012

    of products can help insulate Bayer from economic gyrations. Bayer 's entrenchment in biologics ..... manufacture, and market. Bayer has been establishing a strong ..... invested capital perspective. Bayer AG is a German health-care and

  8. TEXT-S&P summary: Bayer AG

    Headlines

    Mon, 30 Apr 2012

    (The following statement was released by the rating agency)

  9. TEXT-S&P revises Bayer to positive, affirms 'A-/A-2' ratings

    Headlines

    Wed, 25 Apr 2012

    Overview -- Germany-based pharmaceuticals , polymers, and agrochemicals conglomerate Bayer AG continues to deliver strong ..... revising our outlook on Bayer to positive from stable ..... corporate credit ratings on Bayer . -- The positive outlook

  10. Bayer eyes multi-billion euro acquisition -sources

    Headlines

    Wed, 25 Apr 2012

    FRANKFURT, April 25 (Reuters) - German drugs and plastics maker Bayer AG is close to making a multi-billion euro acquisition to bolster its healthcare division, three people close to the planned transaction said.

« Prev12345Next »
Content Partners